[ET Net News Agency, 16 April 2025] HANSOH PHARMA (03692) fell 3.2% to HK$21.45.
It hits an intra-day low of HK$21.45, dipping below the 20-D SMA of HK$22.12, and an intra-day high of HK$22.15. The total shares traded was 4 million, with a value of HK$86.98m. The active buy/sell ratio is 59:41, with net buying turnover of HK$15.29m. UBS accounts for greatest net responsive buying turnover of HK$3.94m, with volume weighted average price of HK$21.782. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive selling turnover of HK$6.7m, with volume weighted average price of HK$21.743. The stock has fallen a combined 5.9% over the past 2 consecutive trading days.
The Hang Seng Index now fell 473 points, or 2.2% to 20,992.
Basic Information| Nominal | 21.450 | % Chg | -3.16% |
| High | 22.150 | Low | 21.450 |
| Shares Tr | 4m | Turnover | 86.98m |
| 10-D SMA | 22.290 | %H.V | 72.614 |
| 20-D SMA | 22.120 | VWAP | 21.734 |
| 50-D SMA | 19.969 | RSI14 | 50.267 |
Status: Dipping below the 20-D SMA, active buy/sell ratio is 59:41, with net buying turnover of HK$15.29m, falling a combined 5.9% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 21.450 | -3.16 |
| SIHUAN PHARM (00460) | 0.610 | -4.69 |
| GRAND PHARMA (00512) | 5.490 | -1.96 |
| SINO BIOPHARM (01177) | 3.550 | -4.57 |
| LIVZON PHARMA (01513) | 25.600 | -1.92 |
| LUYE PHARMA (02186) | 1.800 | -3.23 |
| FOSUN PHARMA (02196) | 13.820 | -3.09 |
| UNI HEALTH (02211) | 0.112 | -1.75 |
| SH PHARMA (02607) | 10.740 | -1.65 |
| CHINARES PHARMA (03320) | 4.840 | -2.42 |
(ed)
Nominal 